Response to IPO Consultation on AI and Inventorship

This is the CIPA response to the IPO consultation on AI and Inventorship, which you can find here.

At present there is no clear consensus as to whether existing AI systems can make an “invention” that could be protected under the patent system, however AI systems are certainly involved in product development and innovation. This raises questions relating to AI systems and inventorship and it is important to provide industry with clear answers to these questions.

The current UK legal position is that a named inventor must be human, and the inventor is defined in statute as the “actual deviser” of the invention. The UK’s “actual deviser” wording has mostly been used to determine inventorship when a team of people has produced an invention, with some of the team making an innovative contribution and others a more routine contribution. This is rather different from the situation in which a human works with an AI system to create an invention.

Therefore case-law relating to the former situation may be difficult to apply to the latter and this might lead to legal uncertainty. In addition, the “devising” definition of UK law is not shared by many other jurisdictions and might restrict patentability in the UK compared with other jurisdictions. In particular, UK patentability may be difficult for inventions made by a human working in close partnership with an AI system if the human cannot clearly demonstrate that they are the “actual devisor” of the invention.

Subject to any possible UK Supreme Court appeal in the DABUS case, a UK patent application naming only an AI system as inventor will be refused by the UK IPO. A similar outcome is expected at the EPO and the USPTO. However, there is a potential for UK outcomes to differ from those in other countries for cases centring on the interpretation of “actual deviser” – such cases might occur as a result of the involvement of an AI system in the creation of the invention.

Many applicants seek patent protection for an invention in multiple countries. CIPA recognises the value and importance of harmonisation across different national and regional patent offices to reduce complexity and improve legal certainty.

Download the full response below.

Date Published: 10 January 2022

More Articles


> Member News, News

Practical considerations around MyEPO/fee changes from 1 April 2024

Read more

> News

UK leads the way in IP-secured lending for high-growth SMEs

Read more

Shopping Basket

No products in the cart.

Skip to content